发明名称 Neuroleptics used to treat psychoses and depression - are N-1-cycloalkyl-alkyl-2-pyrrolidinyl-methyl 2-methoxy 5-tri:fluoro:methyl-benzamide(s)
摘要 <p>N-(1-Cycloalkylalkyl-2-pyrrolidinylmethyl)-2-methoxy-5-trifluorom- ethyl benzamide derivs. of formula (I), as the racemate or enantiomers, and their acid addn. salts are new. where m,n are independently 1,2,3 or 4; the case where both are 1 is specifically claimed. Used to treat depressive states and psychoses by oral, rectal or parenteral admin. in daily doses of 1-200mg. Toxicity tests show the i.p. LD50 in mice varies from 75-200mg/kg. In the Gourmet apomorphine induced climbing antagonism test the cpds. had an i.p. AD50 of 0.03-0.08mg kg.</p>
申请公布号 FR2447911(A1) 申请公布日期 1980.08.29
申请号 FR19790002838 申请日期 1979.02.05
申请人 SYNTHELABO 发明人 JEAN PIERRE KAPLAN HENRY NAJER ET DANIEL CHARLES LEON OBITZ;OBITZ DANIEL CHARLES LEON
分类号 C07D207/09;(IPC1-7):07D207/08;61K31/40 主分类号 C07D207/09
代理机构 代理人
主权项
地址